Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders
Christin Tischner1, Tina Wenz1
1Institute for Genetics and Cluster of Excellence: Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Zülpicher Str. 47A, 50674 Cologne, Germany.
Abstract:
Mitochondrial diseases are very heterogeneous in their genetic cause and clinical manifestation. During the last few decades progress has been made in the diagnosis of mitochondrial diseases, but an established therapy is so far lacking. Several experimental strategies targeting different points of intervention are currently being assessed world-wide. Numerous mouse models of OXPHOS disorders have become available enabling further optimization and validation of therapeutic strategies and paving the way for future clinical trials. In this review, we provide an update on current developments towards treatment as well as the potential and status of transition into therapeutic use.
Insights
Mitochondrial diseases lack established therapies despite diagnostic advances. Research is exploring various treatment strategies, with mouse models aiding therapeutic development for future clinical trials.
Area of Science:
- Biochemistry
- Genetics
- Pharmacology
Background:
- Mitochondrial diseases exhibit significant genetic and clinical heterogeneity.
- Despite diagnostic progress, effective treatments for mitochondrial diseases remain elusive.
- Current research focuses on diverse intervention points for therapeutic development.
Purpose of the Study:
- To review current advancements in the treatment of mitochondrial diseases.
- To assess the potential and readiness of emerging therapies for clinical application.
- To highlight the role of OXPHOS disorder mouse models in therapeutic validation.
Main Methods:
- Literature review of experimental therapeutic strategies.
- Analysis of data from preclinical studies, including mouse models.
- Evaluation of the transition status from research to clinical use.
Main Results:
- Multiple experimental therapeutic strategies are under investigation globally.
- Availability of numerous mouse models facilitates optimization and validation of treatments.
- Progress is being made in translating research findings towards clinical application.
Conclusions:
- While challenges in mitochondrial disease treatment persist, significant research efforts are underway.
- Mouse models are crucial for advancing therapeutic strategies and preparing for clinical trials.
- The transition of novel treatments into clinical practice is a key focus of ongoing research.
More Related Videos
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
08:39Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Animal Mitochondrial Genetics
Mitochondria
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Membranes
